CDC ACIP Recommendation - Use of Respiratory Syncytial Virus Vaccines in Adults Aged 60 and Over
Published: 08/27/2024
Sources:
- Centers for Disease Control and Prevention
Relevant To:
- Assisted Living,
- Medical Office,
- Critical Access Hospitals,
- Hospitals,
- Long Term Care,
- Ambulatory Care,
- Pharmacy,
- Rural Health Clinics
On June 21, 2023, the U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recommended that adults aged ≥60 years may receive a single dose of respiratory syncytial virus (RSV) vaccine, using shared clinical decision-making. RSV is a major cause of respiratory illness and hospitalizations in older adults during fall and winter in the United States.
On June 26, 2024, ACIP voted to update these recommendations as follows:
- All adults aged ≥7…